GoodRx is now publicly available to trade. The stock opened at $46, nearly 40% above it's IPO price of $33.
Launched in 2011, GoodRx allows customers to compare prescription drug prices. It's since become a household name, which may be one of the reasons that the stock has been getting so much buzz. If you're planning to invest, here's how you can buy in.
Offer ends 4/1/25. Customer must fund their Active invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $2,000 is 0.028%. See full terms and conditions at https://www.sofi.com/greenintwoterms/.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – GDRX.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy GoodRx stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
GoodRx stock price (NASDAQ: GDRX)
Use our graph to track the performance of GDRX stocks over time.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
GoodRx price performance over time
Historical closes compared with the close of $4.64 from 2025-03-21
1 week (2025-03-19)
-3.13%
1 month (2025-02-26)
-5.11%
3 months (2024-12-26)
2.65%
6 months (2024-09-26)
-30.75%
1 year (2024-03-26)
-34.28%
2 years (2023-03-24)
-27.27%
3 years (2022-03-25)
17.13
5 years (2020-03-22)
N/A
Is GoodRx stock undervalued or overvalued?
Valuing GoodRx stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GoodRx's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
GoodRx's P/E ratio
GoodRx's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 119x. In other words, GoodRx shares trade at around 119x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, GoodRx's P/E ratio is best considered in relation to those of others within the health information services industry or those of similar companies.
Over the last 12 months, GoodRx's shares have ranged in value from as little as $4.09 up to $9.2599. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while GoodRx's is 1.261. This would suggest that GoodRx's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put GoodRx's beta into context you can compare it against those of similar companies.
GoodRx Holdings, Inc. , together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California. .
Frequently asked questions
What percentage of GoodRx is owned by insiders or institutions? Currently 11.604% of GoodRx shares are held by insiders and 63.469% by institutions.How many people work for GoodRx? Latest data suggests 738 work at GoodRx.When does the fiscal year end for GoodRx? GoodRx's fiscal year ends in December.Where is GoodRx based? GoodRx's address is: 2701 Olympic Boulevard, Santa Monica, CA, United States, 90404What is GoodRx's ISIN number? GoodRx's international securities identification number is: US38246G1085What is GoodRx's CUSIP number? GoodRx's Committee on Uniform Securities Identification Procedures number is: 38246G108
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
